Nutraceutical Combination in Patients With Low-grade Systemic Inflammation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02422927

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
University Of Perugia (from the registry)
Registry
  • NCT NCT02422927
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02422927. Randomized; single masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2015-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nutraceutical Combination in Patients With Low-grade Systemic Inflammation
Condition
Atherosclerosis
Condition
Inflammation
Condition
Hypercholesterolemia
Intervention (Dietary supplement)
Nutraceutical Combination
Intervention (Other)
Standard of Care
Intervention (Other)
Placebo
Lead sponsor
University Of Perugia (class: other)

Record details

Record id
cardio:ct-nct02422927
Content hash
fb7ea684f288143a810fe41c44e0a80cfb496a287a27738f50d2843c36053080